3-49859504-C-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_024046.5(CAMKV):c.1320G>T(p.Glu440Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000218 in 1,614,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024046.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAMKV | NM_024046.5 | c.1320G>T | p.Glu440Asp | missense_variant | 11/11 | ENST00000477224.6 | NP_076951.2 | |
CAMKV | NM_001320147.2 | c.1227G>T | p.Glu409Asp | missense_variant | 12/12 | NP_001307076.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAMKV | ENST00000477224.6 | c.1320G>T | p.Glu440Asp | missense_variant | 11/11 | 1 | NM_024046.5 | ENSP00000419195 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152192Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000956 AC: 24AN: 250984Hom.: 0 AF XY: 0.0000811 AC XY: 11AN XY: 135680
GnomAD4 exome AF: 0.000228 AC: 334AN: 1461878Hom.: 0 Cov.: 33 AF XY: 0.000217 AC XY: 158AN XY: 727246
GnomAD4 genome AF: 0.000118 AC: 18AN: 152192Hom.: 0 Cov.: 33 AF XY: 0.0000942 AC XY: 7AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 29, 2023 | The c.1320G>T (p.E440D) alteration is located in exon 11 (coding exon 10) of the CAMKV gene. This alteration results from a G to T substitution at nucleotide position 1320, causing the glutamic acid (E) at amino acid position 440 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at